Results 171 to 180 of about 253,625 (250)

Next‐Generation Strategies for Neural Repair and Regeneration: Neural Organoid Transplantation in the CNS

Cell Proliferation, Volume 59, Issue 6, June 2026.
Neurological disorders are hard to treat. Stem cell‐derived neural organoids enable research, and their transplantation aids CNS therapy, with this article reviewing relevant advances, challenges and prospects. ABSTRACT Neurological disorders are often devastating and notoriously difficult to repair, creating an urgent need for novel research models ...
Yutong Wang, Jinrui Li, Xingjia Mao, Wanyu Wang, Yansong Li, Xuefei Hu, Jinjie Zhong, Fengdong Zhao, Linlin Wang   +8 more
wiley   +1 more source

Physicians' Perceptions of Prescribing in Pregnancy and Package Inserts: A Survey of General and Hub Hospitals in Japan

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT This study investigated how Japanese physicians make decisions about prescribing medications during pregnancy, based on safety information provided in drug package inserts. An online questionnaire survey targeted physicians working at pregnancy hub hospitals with expertise in drug treatment during pregnancy and physicians in general hospitals ...
Mikako Goto, Naho Yakuwa, Atsuko Murashima   +2 more
wiley   +1 more source

The NF‐κB Signalling Pathway: Mechanisms, Consequences and Therapeutic Targets

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Nuclear Factor‐kappa B (NF‐κB) is a master transcriptional regulator orchestrating critical cellular processes, predominantly immunity and inflammation. However, its aberrant constitutive activation has emerged as a unifying pathogenetic hallmark across diverse malignancies, autoimmune disorders, and chronic inflammatory diseases.
Bherouz Pourdad, Arash Pourdad
wiley   +1 more source

The Discovery of Radium

A promotional card published by the Radium Chemical Company of Pittsburgh PA depicting the discovery of radium by Marie Curie and suggesting its medicinal use in the treatment of uterine ...
Radium Chemical Company
core  

Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. [PDF]

Cancer Sci
Shiota M, Tatarano S, Kamba T, Kamoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Eto M.   +12 more
europepmc   +1 more source

Radium-223 and bone metastatic disease: still more to learn. [PDF]

JNCI Cancer Spectr, 2023
Sartor O.
europepmc   +1 more source

UK real-world data of radium-223 dichloride in metastatic prostate cancer. [PDF]

Nucl Med Commun
Randhawa M, Buchanan G, Stratton IM, Race G, Challapalli A, Bottomley D, Logue J, Sundar S, Robinson A, Mclaren DB, Stevenson R, O'Sullivan JM, Sweeney L, McGrane J, Jiang X, Mazhar D, Khoo V, McPhail N, Jones RJ, National Radium-223 Dichloride Audit Group.   +19 more
europepmc   +1 more source

National Radium Emanator promotional card

Promotional card advertising the National Radium Emanator produced by the National Radium Products Co.
National Radium Products Co.
core  

Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases. [PDF]

Precis Oncol
Lilieholm C, Adeniyi AO, Kwon O, Zaborek J, Kerr CP, Rojas HC, Idrissou MB, Ferreira CA, Clark PA, Clark PA, Jin WJ, Grudzinski JJ, Erbe AK, Hernandez R, Bednarz B, Morris ZS, Weichert JP.   +16 more
europepmc   +1 more source

Prostate cancer – Therapy with radium-223 [PDF]

Revista da Associação Médica Brasileira, 2017
Ana Emília, Brito, Bárbara Juarez, Amorim, Milena, Martello, Wanderley Marques, Bernardo, Elba, Etchebehere   +4 more
openaire   +2 more sources